Avita Medical scoops One Nucleus Summer BioNewsRound Award 2016

/in

Northridge, CA, Perth, Australia and London, United Kingdom – 29 June 2016 Link here.

Read more

Avita Medical Awarded US$7.96m in BARDA Extension Deal

/in

Northridge, CA, Perth, Australia and London, United Kingdom – 27 June 2016 Link here.

Read more

Nexvet Presents Expanded Positive Clinical Data for Ranevetmab (NV-01) and Frunevetmab (NV-02) at ACVIM

/in

DUBLIN, Ireland, June 09, 2016 (GLOBE NEWSWIRE)- Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics company, is today presenting expanded results regarding completed clinical studies for ranevetmab (or “NV-01”) and frunevetmab (or “NV-02”) to veterinarians and veterinary key opinion leaders at a Nexvet-hosted seminar at the American College of Veterinary Internal Medicine (ACVIM) Forum today in […]

Read more

Nexvet Announces Opening of Manufacturing Facility and Production Milestone Achievement

/in

DUBLIN, Ireland, June 03, 2016 (GLOBE NEWSWIRE) – Nexvet Biopharma (Nasdaq:NVET), a veterinary biologic therapeutics developer, today announced the official opening of BioNua Limited, its veterinary biologics manufacturing facility in Tullamore, Ireland, as well as in-house production of its first clinical trial batch of NV-02 from a 200 liter production bioreactor. NV-02 is Nexvet’s monoclonal […]

Read more